Best Options Strategy for KYMR
Looking for the best options strategy for Kymera Therapeutics, Inc. (KYMR)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live KYMR option chain right now, and a simple map from your view on KYMR to the strategy that fits it. Model any of them in the calculator before you trade.
About KYMR
Kymera Therapeutics, Inc. (KYMR) is a major company in Biotechnology. Options traders on KYMR tend to watch , since these can drive large moves in the share price.
About Kymera Therapeutics, Inc.
Kymera Therapeutics is a clinical-stage biopharmaceutical company developing small molecule drugs designed to eliminate disease-causing proteins by exploiting the body's natural protein disposal mechanisms. The company's lead candidate, KT-621, is an oral STAT6 degrader currently in Phase 2b testing for inflammatory and allergic conditions including atopic dermatitis, asthma, COPD, and eosinophilic esophagitis. Its pipeline also includes KT-579, an IRF5 degrader in Phase 1 trials targeting autoimmune diseases like lupus and rheumatoid arthritis, and KT-485, an IRAK4 program in Phase 2 development for conditions such as hidradenitis suppurativa and atopic dermatitis. The company is also exploring a CDK2 program with potential applications across various solid tumors and breast cancer.
Kymera generates revenue primarily through its partnership with Sanofi, which has licensed rights to develop IRAK4-targeting candidates for non-oncology and non-immuno-oncology indications. As a clinical-stage company, it remains pre-commercial and relies on this collaboration, equity financing, and milestone payments to fund operations. Founded in 2015 and based in Watertown, Massachusetts, Kymera…
Today's top-scoring strategy for KYMR
Our engine ranks defined-risk strategies on the live KYMR chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $75 | $1.00 |
| Sell | 1× | PUT | $100 | $2.75 |
| Sell | 1× | CALL | $125 | $2.48 |
| Buy | 1× | CALL | $125 | $2.48 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Live scan from 2026-07-02 · quotes delayed ~15 minutes
Implied volatility
KYMR is currently trading with high implied volatility, which makes its options expensive — and attractive to sell. On the options we scanned that was around 64% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on KYMR currently price in about 64% implied volatility, versus roughly 71% the stock has actually realised over the past month. The two are roughly in line, so neither buying nor selling premium has a clear volatility edge here.
Off that volatility, the options market is pricing a move of about ±$14.26 (±13%) in KYMR by 2026-07-17 — a range of roughly $98.62 to $127. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, downside puts on KYMR trade at a higher implied volatility than upside calls — the market is paying up for crash protection. That skew favours selling put spreads or buying calls over symmetric trades.
Key figures
- Market cap
- $9.3B
- Beta (vs market)
- 2.03
- 52-week range
- $36.65–$130.05 (82% up the range)
- Short interest
- 15.6% of float · 17.3 days to cover
With 15.6% of KYMR's float sold short, squeeze and gap risk are elevated — one reason its options can stay expensive.
How to choose an options strategy for KYMR
Start with your outlook on KYMR, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while KYMR stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open KYMR in the free calculator →
Frequently asked questions
What is the best options strategy for KYMR?
It depends on your outlook. Bullish traders often use a long call or bull call spread on KYMR; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are KYMR options liquid enough to trade?
Kymera Therapeutics, Inc. (KYMR) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade KYMR options?
Buying a single KYMR call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade KYMR or any security. Do your own research.
What does Kymera Therapeutics, Inc. do?
Kymera Therapeutics, Inc. (KYMR) operates in the Biotechnology industry. The "About Kymera Therapeutics, Inc." section above gives a fuller picture of what the company does and how it earns money.
Does Kymera Therapeutics, Inc. pay a dividend?
Kymera Therapeutics, Inc. does not currently pay a dividend, so there is no ex-dividend assignment risk to plan around for options strategies.
Tickers related to KYMR
Comparing KYMR with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 500 North Beacon Street, 4th Floor, Watertown, MA, 02472, United States
- Industry
- Biotechnology
- Employees
- 253
- Phone
- 857 285 5300
- Website
- www.kymeratx.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.